The world of Kedrion Biopharma at a glance:
discover the latest
up-to-date news.

All news.
Kedrion and Kamada Announce FDA Approval of KEDRAB® Label Update
KEDRAB® is now the first and only HRIG available in the U.S. to be clinically studied in children
Read all
First patient enrolled in KIDCARES10
Kedrion Biopharma Pediatric Primary Immunodeficiency Study
Read all
Kedrion Biopharma Phase III Trial, CARES10, achieves important milestone
Kedrion Biopharma, an international biopharmaceutical company specialized in the manufacture and distribution of plasma-derived therapeutic products used in treating rare and serious diseases.
Read all